Your browser doesn't support javascript.
loading
Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-term drug-survival study from the BioCAPTURE registry.
Zweegers, J; van den Reek, J M P A; van de Kerkhof, P C M; Otero, M E; Kuijpers, A L A; Koetsier, M I A; Arnold, W P; Berends, M A M; Weppner-Parren, L; Ossenkoppele, P M; Njoo, M D; Mommers, J M; van Lümig, P P M; Driessen, R J B; Kievit, W; de Jong, E M G J.
Affiliation
  • Zweegers J; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands.
  • van den Reek JM; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands.
  • van de Kerkhof PC; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Otero ME; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Kuijpers AL; Maxima Medisch Centrum, Eindhoven/Veldhoven, the Netherlands.
  • Koetsier MI; Gelre Ziekenhuizen, Apeldoorn, the Netherlands.
  • Arnold WP; Ziekenhuis Gelderse Vallei, Ede, the Netherlands.
  • Berends MA; Slingeland Ziekenhuis, Doetinchem, the Netherlands.
  • Weppner-Parren L; Jeroen Bosch Ziekenhuis, Den Bosch, the Netherlands.
  • Ossenkoppele PM; Ziekenhuisgroep Twente, Almelo, Hengelo, the Netherlands.
  • Njoo MD; Ziekenhuisgroep Twente, Almelo, Hengelo, the Netherlands.
  • Mommers JM; St Anna Ziekenhuis, Geldrop, the Netherlands.
  • van Lümig PP; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Driessen RJ; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Kievit W; Department of Epidemiology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands.
  • de Jong EM; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands.
Br J Dermatol ; 175(2): 340-7, 2016 Aug.
Article in En | MEDLINE | ID: mdl-26989852
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Adalimumab / Ustekinumab / Etanercept / Anti-Inflammatory Agents Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Br J Dermatol Year: 2016 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Adalimumab / Ustekinumab / Etanercept / Anti-Inflammatory Agents Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Br J Dermatol Year: 2016 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom